Insider trade

Director received an award of 405.27 MRK derivative securities

Traded Mar 31, 2026 · Filed Apr 1, 2026

MerckMRK

405.27
Derivative units · @ $120.29

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 31, 2026
Reporting period: Not applicable
Filed with the SEC: Apr 1, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references dividend reinvestment

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000310158-26-000075
Filed / recorded

Apr 1, 2026, 5:44 PM UTC

Added to OQRO

Oct 2, 2026, 3:52 AM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

Merck & Co., Inc.

Issuer CIK

310158

Ticker

MRK

Reporting person

Thomas H Glocer

Relationship

Director

Security

Phantom Stock

Table

Derivative (Table II)

Transaction date

Mar 31, 2026

Transaction code

A

Shares / units

405.2706

Price per share

$120.29

Acquired / disposed

Acquired (A)

Shares owned after

108,293.493

Ownership form

Direct

Amendment

No

Footnotes from the filing

1-for-1
Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
Holdings include shares acquired in dividend reinvestment transactions.